Cancer Center Amsterdam

Sonja Zweegman

PROF.DR.

Full Professor, AII - Immunology Affiliatie VU Full Professor, CCA - Cancer Treatment and quality of life Full Professor, CCA - Cancer biology and immunology Full Professor, Hematology

Specialization

Focus of research

Latest publications

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial
Moreau, P., Hulin, C., Perrot, A., Arnulf, B., Belhadj, K., Benboubker, L., Zweegman, S., Caillon, H. L., Caillot, D., Avet-Loiseau, H., Delforge, M., Dejoie, T., Facon, T., Sonntag, C. C., Fontan, J., Mohty, M., Jie, K-S., Karlin, L., Kuhnowski, F., Lambert, J. R., & 26 othersLeleu, X., Macro, M., Orsini-Piocelle, F., Roussel, M., Schiano de Colella, J. M., van de Donk, N. W. CJ., Wuillème, S., Broijl, A., Touzeau, C., Tiab, M., Marolleau, J-P., Meuleman, N., Vekemans, M-C., Westerman, M., Klein, S. K., Levin, M-D., Offner, F., Escoffre-Barbe, M., Eveillard, J-R., Garidi, R. D., Hua, W., Wang, J., Tuozzo, A., de Boer, C., Rowe, M. & Intergroupe Francophone du Myélome, the Dutch-Belgian Cooperative Trial Group for Hematology Oncology and the CASSIOPEIA Investigators, 1 Aug 2024, In: The Lancet Oncology. 25, 8, p. 1003-1014 12 p.
Research output: Contribution to journal › Article › Academic › peer-review
Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma
Korst, C. L. B. M., O'Neill, C., Bruins, W. S. C., Cosovic, M., Twickler, I., Verkleij, C. P. M., le Clerre, D., Themeli, M., Chion-Sotinel, I., Zweegman, S., Galetto, R., Mutis, T. & van de Donk, N. W. C. J., 25 Jul 2024, In: Journal for Immunotherapy of Cancer. 12, 7, e008769.
Research output: Contribution to journal › Article › Academic › peer-review
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma
Verkleij, C. P. M., O'Neill, C. A., Broekmans, M. E. C., Frerichs, K. A., Bruins, W. S. C., Duetz, C., Kruyswijk, S., Baglio, S. R., Skerget, S., de Oca, R. M., Zweegman, S., Verona, R. I., Mutis, T. & van de Donk, N. W. C. J., 15 Jul 2024, In: Clinical Cancer Research. 30, 14, p. 3006-3022 17 p.
Research output: Contribution to journal › Article › Academic › peer-review
All publications

Cancer Center Amsterdam

Sonja Zweegman

Specialization

Focus of research

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma

T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma